Christine Sheehy
Patrimonio netto: 596 129 $ in data 31/05/2026
Patrimonio netto: 596 129 $ in data 31/05/2026
Christine E.
Sheehy is the founder of Coeptis Pharmaceuticals, Inc. Current jobs include Secretary & Vice President-Compliance at Coeptis Therapeutics, Inc. since 2023, Secretary & Vice President-Compliance at Coeptis Therapeutics Holdings, Inc. since 2023, and Chief Human Resources & Senior Vice President at Henry Schein, Inc. since 2024.
Former jobs include Principal at AMETEK, Inc., Senior Vice President-Operations at Three Rivers Pharmaceuticals LLC from 2001 to 2010, Manager-Business Consulting at Schneider Downs & Co., Inc., Senior Vice President-Operations at Kadmon Pharmaceuticals LLC from 2010 to 2016, and Manager-Technology at Banco Real SA from 1989 to 1996.
Education includes undergraduate studies at The Pennsylvania State University and the State University of New York at Albany.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
0,12% | 11/02/2026 | 64.031 ( 0,12% ) | 596 129 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| NAERODYNAMICS INC | Responsabile della Conformità | 17/05/2023 |
| HENRY SCHEIN, INC. | Ufficiale delle Risorse Umane | 01/11/2024 |
Coeptis Pharmaceuticals, Inc.
Coeptis Pharmaceuticals, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Fondatore | - |
| Società | Posizione | Fine |
|---|---|---|
Kadmon Pharmaceuticals LLC
Kadmon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | 01/01/2016 |
Three Rivers Pharmaceuticals LLC
Three Rivers Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets pharmaceutical therapies | Direttore operativo | 01/01/2010 |
Banco Real SA
Banco Real SA Major BanksFinance International bank | Corporate Officer/Principal | 01/04/1996 |
| COEPTIS THERAPEUTICS | Direttore Finanziario/CFO | 17/05/2023 |
| AMETEK, INC. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
AMETEK, Inc.
AMETEK, Inc. Electrical ProductsProducer Manufacturing Manufactures and supplies electronic instruments and electromechanical devices | Producer Manufacturing |
Henry Schein, Inc.
Henry Schein, Inc. Medical DistributorsDistribution Services Distributes healthcare products and services | Distribution Services |
Coeptis Therapeutics, Inc.
Coeptis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies novel therapy products for cancer patients | Health Technology |
Three Rivers Pharmaceuticals LLC
Three Rivers Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets pharmaceutical therapies | Health Technology |
Schneider Downs & Co., Inc.
Schneider Downs & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Banco Real SA
Banco Real SA Major BanksFinance International bank | Finance |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Albany
State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kadmon Pharmaceuticals LLC
Kadmon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Coeptis Pharmaceuticals, Inc.
Coeptis Pharmaceuticals, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Coeptis Therapeutics Holdings, Inc.
Coeptis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing innovative cell therapy platforms for patients with cancer | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale